Q1 2016 13F Holders as of 3/31/2016
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
71.9M
-
Number of holders
-
33
-
Total 13F shares, excl. options
-
12.1M
-
Shares change
-
-572K
-
Total reported value, excl. options
-
$77.3M
-
Value change
-
-$2.87M
-
Number of buys
-
18
-
Number of sells
-
-19
-
Price
-
$6.39
Significant Holders of SINOVAC BIOTECH LTD. - Common Shares (SVA) as of Q1 2016
42 filings reported holding SVA - SINOVAC BIOTECH LTD. - Common Shares as of Q1 2016.
SINOVAC BIOTECH LTD. - Common Shares (SVA) has 33 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 12.1M shares
of 71.9M outstanding shares and own 16.83% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (5.25M shares), ORBIMED ADVISORS LLC (2.67M shares), RENAISSANCE TECHNOLOGIES LLC (1.33M shares), FIRST MANHATTAN CO (1M shares), UNITED SERVICES AUTOMOBILE ASSOCIATION (359K shares), CITIGROUP INC (284K shares), Eqis Capital Management, Inc. (219K shares), Pine River Capital Management L.P. (185K shares), DEUTSCHE BANK AG\ (155K shares), and Invesco Ltd. (106K shares).
This table shows the top 33 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.